Primary Site >> Biliary tract Cancer

Gene >> MAPK14

  • 1999
  • 2001
  • 2002
  • 2003
  • 2004
  • 2005
  • 2006
  • 2010
  • 2012
  • 2014
  • 2016
  • 2017
  • 2018
Ref: Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line.
PMID: 10534331
 Ref: Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line.
PMID: 11124819
 Ref: Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line.
PMID: 11910351
Ref: Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells.
PMID: 12143044
 Ref: Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma.
PMID: 12717393
Ref: Translational regulation by p38 mitogen-activated protein kinase signaling during human cholangiocarcinoma growth.
PMID: 12829998
 Ref: Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways.
PMID: 14701718
 Ref: IL-6 activates serum and glucocorticoid kinase via p38alpha mitogen-activated protein kinase pathway.
PMID: 15917303
 Ref: Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangiocytes.
PMID: 16336976
Ref: Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.
PMID: 16469407
Ref: The effects of ZD1839 (Iressa), a highly selective EGFR tyrosine kinase inhibitor, as a radiosensitiser in bile duct carcinoma cell lines.
PMID: 16525641
 Ref: p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion.
PMID: 19816939
 Ref: The tyrosine kinase c-Met contributes to the pro-tumorigenic function of the p38 kinase in human bile duct cholangiocarcinoma cells.
PMID: 23024367
 Ref: MicroRNA-135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer.
PMID: 24903309
Ref: WWOX suppresses cell growth and induces cell apoptosis via inhibition of P38 nuclear translocation in cholangiocarcinoma.
PMID: 25502636
 Ref: CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.
PMID: 27176078
Ref: Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo.
PMID: 27349455
 Ref: S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway.
PMID: 28984474
 Ref: DUSP1 enhances the chemoresistance of gallbladder cancer via the modulation of the p38 pathway and DNA damage/repair system.
PMID: 30008878
Ref: S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma.
PMID: 30182496
Ref: IDH1 mutation correlates with a beneficial prognosis and suppresses tumor growth in IHCC.
PMID: 30278918